tirzepatide
Brand: MOUNJARO
approved
Quick answer
tirzepatide (MOUNJARO), is a pharmaceutical active ingredient, with approved status in the US.
Key facts
- INN
- tirzepatide
- Brand
- MOUNJARO
- Route
- SUBCUTANEOUS
- Formulation
- SOLUTION
Related news
Novo Nordisk Reports Record Q1 Revenue Driven by Wegovy and Ozempic Demand
Novo Nordisk has reported record Q1 revenue driven by strong demand for Wegovy and Ozempic. This article analyzes the implications for investors and the competitive landscape.
FDA Approves Mounjaro: Key Details on Tirzepatide for Obesity
The FDA has officially approved Mounjaro, a new medication containing tirzepatide, for the treatment of obesity, offering hope for effective weight management.
Frequently asked questions
What is tirzepatide?
tirzepatide (MOUNJARO), is a pharmaceutical active ingredient, with approved status in the US.
What is the brand name for tirzepatide?
MOUNJARO is a marketed brand name for tirzepatide. Check FDA Drugs@FDA for the current US label holder.